Weight-loss drug Wegovy can be marketed for heart benefits after FDA label update
CNN —
Wegovy’s not just for weight loss anymore.
The US Food and Drug Administration on Friday approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the medicine’s label, making it the first weight-loss drug to also be clear... [3716 chars]
Source: CNN
